CXCL10 and tropical spastic paraparesis: We have already shown that HAM/TSP patients can be classified into three groups according to disease activity, which is assessed on the basis of CSF concentrations of CXCL10 and neopterin (Sato et al., 2018b) and clinical progression rate.